drugset / Trial / NCT00757198

Requirement of Analgesics After Two Remifentanil Dosing Regimen in Cardiac Surgery.

NCT00757198 ↗

Phase 4 Completed 90 enrolled Kuopio University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Prospective double blind study comparing two remifentanil dosing protocols (0.1 and 0.3 mcg/kg/min) during cardiac surgery. Main outcome measures are postoperative opioid requirements (PCA oxycodone) and postoperative pain (VAS, verbal rating scale).

Timeline

Start
2008-09
Primary completion
2011-11
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Remifentanil Small molecule 0.1 ug/kg —
Comparator Remifentanil Small molecule 0.3 ug/kg —

Indications

No indication recorded.